CCL4 and plasma cell myeloma: Beyond its involvement in metabolic diseases and cancers, CCL4 plays a role in the development of systemic lupus erythematosus, multiple sclerosis, multiple myeloma, psoriasis, cystic fibrosis, and sarcoidosis.